References
- 1. Vaziri, N. D.; Pahl, M. V; Crum, A.; Norris, K. Effect of uremia on structure and function of immune system. J. Ren. Nutr. 2012; 22: 149–156, doi:10.1053/j.jrn.2011.10.020.10.1053/j.jrn.2011.10.020
- 2. Pahl, M. V; Gollapudi, S.; Sepassi, L.; Gollapudi, P.; Elahimehr, R.; Vaziri, N. D. Effect of end-stage renal disease on B-lymphocyte sub-populations, IL-7, BAFF and BAFF receptor expression. Nephrol. Dial. Transplant 2010; 25: 205–212, doi:10.1093/ndt/gfp397.10.1093/ndt/gfp397
- 3. Knerr, K.; Futh, R.; Hemsen, P.; Mohne, W.; Heinig, A.; Kleophas, W.; Scherbaum, W. A.; Martin, S. Chronic inflammation and hemodialysis reduce immune competence of peripheral blood leukocytes in end-stage renal failure patients. Cytokine 2005; 30: 132–138, doi:10.1016/j.cyto.2004.12.011.10.1016/j.cyto.2004.12.01115826820
- 4. Kay, N. E. Natural killer cells. Crit. Rev. Clin. Lab. Sci. 1986; 22: 343–359.241903410.3109/10408368509165790
- 5. Bender, B. S.; Curtis, J. L.; Nagel, J. E.; Chrest, F. J.; Kraus, E. S.; Briefel, G. R.; Adler, W. H. Analysis of immune status of hemodialyzed adults: association with prior transfusions. Kidney Int. 1984; 26: 436–443.10.1038/ki.1984.193
- 6. Raij, L.; Kay, N. E. Effect of hemodialysis membranes on human lymphocyte natural killer function. Contrib. Nephrol. 1987; 59: 17–25.
- 7. Kay, N. E.; Raij, L. Differential effect of hemodialysis membranes on human lymphocyte natural killer function. Artif. Organs 1987; 11: 165–167.10.1111/j.1525-1594.1987.tb02651.x
- 8. Cala, S.; Mazuran, R.; Kordic, D. Negative effect of uraemia and cuprophane haemodialysis on natural killer cells. Nephrol. Dial. Transplant 1990; 5: 437–440.2122320
- 9. Zaoui, P.; Hakim, R. M. Natural killer-cell function in hemodialysis patients: effect of the dialysis membrane. Kidney Int. 1993; 43: 1298–1305.831594210.1038/ki.1993.182
- 10. Gascon, A.; Orfao, A.; Lerma, J. L.; Ciudad, J.; Lopez, A.; Hernandez, M. D.; Tabernero, J. M. Antigen phenotype and cytotoxic activity of natural killer cells in hemodialysis patients. Am. J. Kidney Dis. 1996; 27: 373–379.8604706
- 11. Vacher-Coponat, H.; Brunet, C.; Lyonnet, L.; Bonnet, E.; Loundou, A.; Sampol, J.; Moal, V.; Dussol, B.; Brunet, P.; Berland, Y.; Dignat-George, F.; Paul, P. Natural killer cell alterations correlate with loss of renal function and dialysis duration in uraemic patients. Nephrol. Dial. Transplant 2008; 23: 1406-1414, doi:10.1093/ndt/gfm596.10.1093/ndt/gfm596
- 12. Griveas, I.; Visvardis, G.; Fleva, A.; Papadopoulou, D.; Mitsopoulos, E.; Kyriklidou, P.; Manou, E.; Ginikopoulou, E.; Meimaridou, D.; Paulitou, A.; Sakellariou, G. Comparative analysis of immunophenotypic abnormalities in cellular immunity of uremic patients undergoing either hemodialysis or continuous ambulatory peritoneal dialysis. Ren. Fail. 2005; 27: 279–282.
- 13. Degiannis, D.; Czarnecki, M.; Donati, D.; Homer, L.; Eisinger, R. P.; Raska, K. J.; Raskova, J. Normal T lymphocyte function in patients with end-stage renal disease hemodialyzed with “high-flux” polysulfone membranes. Am. J. Nephrol. 1990; 10: 276–282, doi:10.1159/000168120.
- 14. Canaud, B.; Chenine, L.; Henriet, D.; Leray, H. Online hemodiafiltration: a multipurpose therapy for improving quality of renal replacement therapy. Contrib. Nephrol. 2008; 161: 191–198, doi:10.1159/000130677.10.1159/000130677
- 15. Daugirdas, J. T.; Depner, T. A.; Gotch, F. A.; Greene, T.; Keshaviah, P.; Levin, N. W.; Schulman, G. Comparison of methods to predict equilibrated Kt/V in the HEMO Pilot Study. Kidney Int. 1997; 52: 1395–1405.
- 16. Deenitchina, S. S.; Ando, T.; Okuda, S.; Kinukawa, N.; Hirakata, H.; Nagashima, A.; Fujishima, M. Cellular immunity in hemodialysis patients: a quantitative analysis of immune cell subsets by flow cytometry. Am. J. Nephrol. 1995; 15: 57–65, doi:10.1159/000168802.10.1159/000168802
- 17. Peraldi, M.-N.; Berrou, J.; Metivier, F.; Toubert, A. Natural killer cell dysfunction in uremia: the role of oxidative stress and the effects of dialysis. Blood Purif. 2013, 35 Suppl 2, 14–19, doi:10.1159/000350839.10.1159/000350839
- 18. Renaux, J. L.; Thomas, M.; Crost, T.; Loughraieb, N.; Vantard, G. Activation of the kallikrein-kinin system in hemodialysis: role of membrane electronegativity, blood dilution, and pH. Kidney Int. 1999; 55: 1097–1103, doi:10.1046/j.1523-1755.1999.0550031097.x.10.1046/j.1523-1755.1999.0550031097.x
- 19. Alexiewicz, J. M.; Smogorzewski, M.; Fadda, G. Z.; Massry, S. G. Impaired phagocytosis in dialysis patients: studies on mechanisms. Am. J. Nephrol. 1991; 11: 102–111, doi:10.1159/000168284.10.1159/000168284
- 20. Ballen, K. K.; Shpall, E. J.; Avigan, D.; Yeap, B. Y.; Fisher, D. C.; McDermott, K.; Dey, B. R.; Attar, E.; McAfee, S.; Konopleva, M.; Antin, J. H.; Spitzer, T. R. Phase I trial of parathyroid hormone to facilitate stem cell mobilization. Biol. Blood Marrow Transplant. 2007; 13: 838-843, doi:10.1016/j.bbmt.2007.03.007.10.1016/j.bbmt.2007.03.007
- 21. Yamamoto, I.; Potts Jr, J. T.; Segre, G. V Circulating bovine lymphocytes contain receptors for parathyroid hormone. J. Clin. Invest. 1983; 71: 404-407, doi:10.1172/JCI110784.10.1172/JCI110784
- 22. Klinger, M.; Alexiewicz, J. M.; Linker-Israeli, M.; Pitts, T. O.; Gaciong, Z.; Fadda, G. Z.; Massry, S. G. Effect of parathyroid hormone on human T cell activation. Kidney Int. 1990; 37: 1543–1551.
- 23. Geara, A. S.; Castellanos, M. R.; Bassil, C.; Schuller-Levis, G.; Park, E.; Smith, M.; Goldman, M.; Elsayegh, S. Effects of parathyroid hormone on immune function. Clin. Dev. Immunol. 2010, 2010, doi:10.1155/2010/418695.10.1155/2010/418695
- 24. Ozdemir, F. N.; Yakupoglu, U.; Turan, M.; Arat, Z.; Karakayali, H.; Erdal, R.; Turan, M. Role of parathormone levels on T-cell response in hemodialysis patients. Transplant. Proc. 2002; 34: 2044–2045.
- 25. Angelini, D.; Carlini, A.; Giusti, R.; Grassi, R.; Mei, E.; Fiorini, I.; Mazzotta, L.; Antonelli, A. Parathyroid hormone and T-cellular immunity in uremic patients in replacement dialytic therapy. Artif. Organs 1993; 17: 73–75.